Loading clinical trials...

A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITINGPHASE1

A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants

Assessment of the Relative Bioavailability of ABBV-932 Formulations in Healthy Adult Subjects

NCT06849791•AbbVie

View on ClinicalTrials.gov

Summary

This study will assess the relative bioavailability and effect of food on pharmacokinetics of ABBV-932 oral administration in healthy adult participants.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Body Mass Index (BMI) ≥ 18.0 to ≤ 32.0 kg/m\^2 after rounding to the tenths decimal at the time of screening and upon initial confinement. BMI is calculated as weight in kg divided by the square of height measured in meters.
•A condition of general good health, based upon the results of a medical history, physical examination, vital signs, laboratory profile, and a 12-lead ECG

Exclusion Criteria

•History of epilepsy, any clinically significant cardiac, respiratory (except mild asthma as a child), renal, hepatic, gastrointestinal, hematologic or psychiatric disease or disorder, or any uncontrolled medical illness.
•History of any clinically significant sensitivity or allergy to any medication or food.

Locations (1)

Acpru /Id# 266649

Grayslake, Illinois, United States

Key Dates

Start Date

February 26, 2025

Primary Completion Date

March 1, 2026

Completion Date

March 1, 2026

Last Updated

February 24, 2026

Enrollment

ACTUAL participants

Conditions

Healthy Volunteer

Interventions

ABBV-932

DRUG

ABBV-932

DRUG

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

NCT07310264

Healthy Volunteers (HV)Parkinson's Disease (PD)

View study

RECRUITING

Collection of Data and Samples From Healthy Donors for Use in Translational Research

NCT00090662

Healthy Volunteer

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 24, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants

Inclusion Criteria

Exclusion Criteria

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

Collection of Data and Samples From Healthy Donors for Use in Translational Research

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

A Study of ENX-104 in Healthy Participants

Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle